"Dear Doctor - Participate in this fun and exciting Quiz on Neonatal jaundice. Neonatal jaundice is a yellowing of the skin and eyes in newborn infants. It occurs when there is an excess of bilirubin, a yellow pigment that is produced when red blood cells break down. Bilirubin is normally removed from the body by the liver, but in newborns, the liver is not yet fully developed and cannot remove bilirubin efficiently. As a result, bilirubin can build up in the blood and cause jaundice. Jaundice itself is not harmful and will usually go away on its own within 2 to 3 weeks. However, if left untreated, it can lead to serious complications such as brain damage or kernicterus. Kernicterus is a type of brain damage that can occur when bilirubin levels are very high and enter the brain. For this reason, it is important to monitor neonatal jaundice closely and treat it promptly if necessary. Participate Now."
1.
Targeted radiation therapy shows near-complete response in rare sarcoma patients
2.
Dostarlimab Boosts Long-Term Survival in Endometrial Cancer
3.
Germline Profiling May Improve Risk Stratification in t-MNs
4.
Results for Prostate Cancer Are Associated With PSA Nadir 6 Months After Primary RT.
5.
Scientists call into question safety of potential new anticancer treatment
1.
Understanding Macrocytosis: Causes, Symptoms, and Treatment Options
2.
Gender-Specific Dual Antiplatelet Therapy Strategies for Women After PCI
3.
Unlocking the Mystery of Hemoglobin C Trait: A Closer Look at a Rare Blood Disorder
4.
Ferroptosis Signaling in Tumor Progression and Therapeutic Resistance
5.
Exploring New Treatment Options for Hemophilia: A Journey into the Unknown
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
2.
Navigating the Complexities of Ph Negative ALL - Part XV
3.
Clinical Insights in Hematology
4.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
5.
Updates on the First Line Management of ALK+ NSCLC
Recommended News For You
1.
Rectal Cancer 'Crisis'; Smells Like Cancer; Flushing Away Clues to Colon Cancer
2.
Body Clock Genes Tied to Prostate Radiotherapy Toxicity
3.
Patients face high out-of-pocket costs after incident cancer diagnosis
4.
High Rate of Surgical Success in Complex NSCLC With Neoadjuvant Chemoimmunotherapy
5.
When BCG is not effective in treating bladder cancer, Oncolytic Virus exhibits high response rates.
Conferences That Might Interest You
Recommended Articles For You
1.
Landmark Medical Oncology Trials Redefining Early Breast Cancer Management
2.
Revolutionizing Cancer Treatment with Trilaciclib: How a New Drug is Transforming Outcomes
3.
The Mysterious World of Petechiae: Exploring Causes and Treatments
4.
Precision Oncology: Integrating Genomics and Data to Shape Cancer Care’s Future
5.
The Essential Guide to Understanding Fibrinogen and Its Role in Blood Clotting
Boost Your Knowledge With These Quizzes
1.
Quiz on Lipid-Lowering Therapies: PCSK9 Inhibitors vs. Statins - How do they compare in hyperlipidemia management?
2.
Quiz on DOACs Demystified: Navigating Guidelines and Overcoming Clinical Challenges
3.
Quiz on Upper Extremity Tendon Injury Management: How Well Do You Know Assessment and Treatment?
4.
Quiz on Pancreas Power: What You Know About Its Role in Diabetes
5.
Quiz on Vaccination Policies for Healthcare Workers: What Are the Essential Guidelines and Best Practices for Ensuring Compliance and Safety in Healthcare Environments?
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation